Tag: Crps

The global prevalence of Complex Regional Pain Syndrome (CRPS) is estimated to be between 5.5 and 26.2 per 100,000 people annually [1.5.1]. Understanding what painkillers are used for CRPS is key to managing this debilitating neuropathic pain condition.

Neridronate, an aminobisphosphonate, is licensed in Italy for treating conditions like Complex Regional Pain Syndrome (CRPS) and Osteogenesis Imperfecta (OI) [1.5.1]. So, is neridronate available in the US? The short answer is no, it is not currently approved by the FDA [1.2.1, 1.3.1].

The stellate ganglion block procedure can take as little as 15 minutes to perform. A key component of this minimally invasive treatment is understanding **what medication is injected in a stellate ganglion block** to temporarily interrupt nerve signals and provide relief for a variety of conditions.